(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 43.24%-487M | -37.53%5.07B | -12.37%4.15B | -153.42%-469M | -12.31%2.24B | -1,283.87%-858M | 108.70%8.11B | 30.22%4.74B | 156.10%878M | 30.11%2.56B |
Net income from continuing operations | -71.35%165M | -83.32%1.28B | -84.26%176M | -94.82%82M | -87.56%448M | -58.41%576M | 141.81%7.69B | -7.37%1.12B | 118.04%1.58B | 223.54%3.6B |
Operating gains losses | -137.35%-31M | 215.47%209M | 111.90%5M | 65.43%-28M | 463.16%69M | 243.10%83M | -284.69%-181M | ---42M | ---81M | ---19M |
Depreciation and amortization | 13.91%565M | 7.80%2.17B | 8.65%565M | 4.94%552M | 10.10%556M | 7.59%496M | 3.13%2.01B | 4.63%520M | 7.57%526M | 4.12%505M |
Asset impairment expenditure | ---- | 199.23%774M | --76M | --0 | 255.11%698M | ---- | -2,463.64%-780M | --0 | -4,814.29%-330M | -45,100.00%-450M |
Remuneration paid in stock | -60.00%6M | -122.22%-14M | 88.14%-7M | 7.69%42M | -23.08%-64M | -88.89%15M | -68.18%63M | -180.82%-59M | -39.06%39M | -236.84%-52M |
Deferred tax | 239.22%71M | -112.75%-58M | -242.16%-145M | -75.76%56M | 22.39%82M | -192.73%-51M | 1,567.74%455M | 54.55%102M | 365.52%231M | 435.00%67M |
Other non cashItems | 814.29%64M | 9,750.00%197M | 627.59%153M | 766.67%26M | 435.29%91M | -76.67%7M | -98.32%2M | -170.73%-29M | 125.00%3M | -83.00%17M |
Change In working capital | 33.11%-1.33B | 144.16%507M | 6.43%3.33B | -9.70%-1.2B | 132.67%363M | 4.15%-1.98B | 30.89%-1.15B | 91.31%3.13B | 60.28%-1.09B | -546.18%-1.11B |
-Change in receivables | -148.04%-257M | 195.65%879M | -11.67%2.37B | -49.44%627M | 32.55%-2.65B | 158.86%535M | 44.94%-919M | 87.36%2.68B | 566.17%1.24B | -60.99%-3.93B |
-Change in inventory | 10.92%-1.33B | ---- | ---- | 63.64%846M | 113.27%3.73B | 42.78%-1.49B | ---- | ---- | 297.69%517M | -5.41%1.75B |
-Change in prepaid assets | ---- | 217.91%1.38B | 119.04%416M | -18.18%-52M | -0.88%337M | ---- | -414.10%-1.17B | -100.09%-2.19B | 66.92%-44M | 9.68%340M |
-Change in payables and accrued expense | 125.34%260M | -286.35%-1.75B | 29.03%2.95B | 6.63%-2.62B | -242.92%-1.05B | -241.32%-1.03B | -44.63%938M | -22.47%2.28B | -13.01%-2.81B | 37.45%734M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 43.24%-487M | -37.53%5.07B | -12.37%4.15B | -153.42%-469M | -12.31%2.24B | -1,283.87%-858M | 108.70%8.11B | 30.22%4.74B | 156.10%878M | 30.11%2.56B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 28.82%-494M | -1.96%-2.96B | 40.02%-733M | 4.54%-673M | -65.96%-858M | -51.86%-694M | -60.54%-2.9B | -162.80%-1.22B | -34.80%-705M | -19.95%-517M |
Capital expenditure reported | 19.78%-373M | -7.92%-2.67B | 17.80%-831M | 3.30%-615M | -62.47%-775M | -32.48%-465M | -31.37%-2.48B | -56.50%-1.01B | -29.27%-636M | -6.47%-477M |
Net business purchase and sale | --0 | 62.41%-153M | 88.75%-37M | --0 | ---92M | -170.73%-111M | -362.50%-407M | -1,727.78%-329M | 66.67%-10M | --0 |
Net investment purchase and sale | ---19M | ---92M | --0 | --0 | 81.48%-5M | --0 | ---- | ---- | --0 | ---27M |
Net other investing changes | 13.56%-102M | -121.05%-42M | 14.41%135M | 1.69%-58M | 207.69%14M | -81.54%-118M | -111.52%-19M | -40.70%118M | -5,800.00%-59M | -136.11%-13M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 28.82%-494M | -1.96%-2.96B | 40.02%-733M | 4.54%-673M | -65.96%-858M | -51.86%-694M | -60.54%-2.9B | -162.80%-1.22B | -34.80%-705M | -19.95%-517M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -74.26%548M | 56.44%-2.06B | 10.84%-3.04B | 3,465.52%976M | -13.10%-2.12B | 262.07%2.13B | -57.54%-4.73B | -9.36%-3.41B | -103.83%-29M | -318.26%-1.88B |
Net issuance payments of debt | -75.04%816M | -97.17%19M | -44.09%-2.78B | -35.36%1.24B | -149.63%-1.71B | 138.09%3.27B | 160.98%672M | 2.57%-1.93B | 83.32%1.91B | -265.24%-683M |
Net common stock issuance | 100.12%1M | 76.70%-1.01B | 100.08%1M | 100.06%1M | 84.13%-147M | -68.41%-869M | -421.20%-4.35B | -39.06%-1.21B | -7,273.91%-1.7B | -4,730.00%-926M |
Cash dividends paid | -6.10%-261M | -0.10%-1.03B | -4.38%-262M | -0.77%-261M | 0.38%-263M | 4.28%-246M | 1.34%-1.03B | 5.64%-251M | 0.77%-259M | -0.38%-264M |
Net other financing activities | 68.00%-8M | -70.00%-34M | --0 | ---- | -80.00%-9M | -108.33%-25M | 4.76%-20M | ---17M | 800.00%14M | 73.68%-5M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -74.26%548M | 56.44%-2.06B | 10.84%-3.04B | 3,465.52%976M | -13.10%-2.12B | 262.07%2.13B | -57.54%-4.73B | -9.36%-3.41B | -103.83%-29M | -318.26%-1.88B |
Net cash flow | ||||||||||
Beginning cash position | 4.44%941M | 80.56%901M | -32.69%554M | 3.66%737M | 155.29%1.47B | 80.56%901M | -65.68%499M | 85.78%823M | -60.37%711M | -18.96%577M |
Current changes in cash | -175.04%-433M | -90.17%47M | 267.65%375M | -215.28%-166M | -553.37%-739M | 736.23%577M | 151.73%478M | 96.15%102M | 110.82%144M | -84.99%163M |
Effect of exchange rate changes | -140.00%-12M | 90.79%-7M | 150.00%12M | 46.88%-17M | 110.34%3M | -155.56%-5M | -145.16%-76M | -700.00%-24M | -60.00%-32M | -625.00%-29M |
End cash Position | -66.33%496M | 4.44%941M | 4.44%941M | -32.69%554M | 3.66%737M | 155.29%1.47B | 80.56%901M | 80.56%901M | 85.78%823M | -60.37%711M |
Free cash from | 35.00%-860M | -57.50%2.4B | -10.90%3.32B | -547.93%-1.08B | -29.46%1.47B | -220.34%-1.32B | 181.47%5.64B | 24.54%3.73B | 111.76%242M | 37.09%2.08B |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.